Retour

Choisissez votre région

Corporate

Demandez un entretien de conseil sur les cellules souches

En savoir plus

Liste des patients
traités

Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:

Image
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Nr. Source Type de source Diagnostic Domaine médical Année d’application Thérapie Pays Âge du bénéficiaire
7301 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
7302 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 58
7303 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
7304 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
7305 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
7306 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
7307 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
7308 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 57
7309 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
7310 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 59
7311 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
7312 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
7313 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 69
7314 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
7315 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
7316 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
7317 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
7318 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
7319 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
7320 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 53
7321 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
7322 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 44
7323 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
7324 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
7325 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 60
7326 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
7327 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
7328 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 60
7329 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 3
7330 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 56
7331 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
7332 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 75
7333 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
7334 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
7335 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 46
7336 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 53
7337 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 71
7338 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 50
7339 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
7340 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 67
7341 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
7342 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 68
7343 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 59
7344 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
7345 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
7346 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
7347 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
7348 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
7349 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
7350 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 49
7351 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 39
7352 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 67
7353 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
7354 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 76
7355 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 70
7356 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 53
7357 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
7358 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
7359 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 66
7360 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 68
7361 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
7362 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 61
7363 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 61
7364 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 22
7365 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 40
7366 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 57
7367 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
7368 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 70
7369 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 51
7370 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 53
7371 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Germany 68
7372 Apheresis Allogeneic Myelodysplastic Syndrome In Fanconi Anemia Hematology 2017 Standard Therapy Poland 23
7373 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Of Blasts Hematology 2017 Standard Therapy Germany 62
7374 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 63
7375 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 63
7376 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 66
7377 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
7378 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 55
7379 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
7380 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 62
7381 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Poland 72
7382 Apheresis Allogeneic Myelofibrosis Hematology 2017 Standard Therapy Germany 70
7383 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2017 Standard Therapy Poland 47
7384 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 44
7385 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 56
7386 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 57
7387 Apheresis Allogeneic Myeloma Multiplex Hematology 2017 Standard Therapy Poland 38
7388 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2017 Standard Therapy Poland 7
7389 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2017 Standard Therapy Germany 37
7390 Apheresis Allogeneic Niemann–Pick Disease Hematology 2017 Standard Therapy Poland 2
7391 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 36
7392 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 58
7393 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 53
7394 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 1
7395 Apheresis Allogeneic No Data Hematology 2017 Standard Therapy Poland 55
7396 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 63
7397 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 56
7398 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 47
7399 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 57
7400 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 65